title: Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.
abstract: Th1 and Th17 T cells are often colocalized in pathological environments, yet Th1-derived IFN-gamma inhibits Th17 cell development in vitro. We explored the physiologic basis of this paradox in humans. In this study, we demonstrate increased the number of CD4(+) and CD8(+) IL-17(+) T cells in skin lesions of psoriasis. Furthermore, we show that myeloid APCs potently support induction of IL-17(+) T cells, and that this activity is greatly increased in psoriasis. We tested stimuli that might account for this activity. Th1 cells and IFN-gamma are increased in psoriatic blood and lesional skin. We show that IFN-gamma programs myeloid APCs to induce human IL-17(+) T cells via IL-1 and IL-23. IFN-gamma also stimulates APC production of CCL20, supporting migration of IL-17(+) T cells, and synergizes with IL-17 in the production of human beta-defensin 2, an antimicrobial and chemotactic protein highly overexpressed by psoriatic keratinocytes. This study reveals a novel mechanistic interaction between Th1 and IL-17(+) T cells, challenges the view that Th1 cells suppress Th17 development through IFN-gamma, and suggests that Th1 and IL-17(+) T cells may collaboratively contribute to human autoimmune diseases.
authors.affiliation: Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48105, USA.
authors.forename: Ilona
authors.initials: I
authors.lastname: Kryczek
authors.forename: Allen T
authors.initials: AT
authors.lastname: Bruce
authors.forename: Johann E
authors.initials: JE
authors.lastname: Gudjonsson
authors.forename: Andrew
authors.initials: A
authors.lastname: Johnston
authors.forename: Abhishek
authors.initials: A
authors.lastname: Aphale
authors.forename: Linhua
authors.initials: L
authors.lastname: Vatan
authors.forename: Wojciech
authors.initials: W
authors.lastname: Szeliga
authors.forename: Yin
authors.initials: Y
authors.lastname: Wang
authors.forename: Yan
authors.initials: Y
authors.lastname: Liu
authors.forename: Theodore H
authors.initials: TH
authors.lastname: Welling
authors.forename: James T
authors.initials: JT
authors.lastname: Elder
authors.forename: Weiping
authors.initials: W
authors.lastname: Zou
mesh_terms: D000938:Antigen-Presenting Cells / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002450:Cell Communication / Q000276:immunology; D002465:Cell Movement / Q000276:immunology*; D002478:Cells, Cultured; D018920:Coculture Techniques; D006801:Humans; D016130:Immunophenotyping; D007371:Interferon-gamma / Q000502:physiology*; D020381:Interleukin-17 / Q000096:biosynthesis* / Q000378:metabolism / Q000502:physiology; D022423:Myeloid Cells / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D011565:Psoriasis / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D012867:Skin / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism / Q000473:pathology
chemical_list: D020381:Interleukin-17; D007371:Interferon-gamma
references.citation: J Immunol. 2000 Jun 15;164(12):6621-32
references.pmid: 10843722
references.citation: J Invest Dermatol. 2008 May;128(5):1207-11
references.pmid: 18200064
references.citation: J Invest Dermatol. 2001 Sep;117(3):569-75
references.pmid: 11564161
references.citation: Adv Dermatol. 2001;17:211-41
references.pmid: 11758117
references.citation: J Biol Chem. 2003 Jan 17;278(3):1910-4
references.pmid: 12417590
references.citation: Nature. 2003 Feb 13;421(6924):744-8
references.pmid: 12610626
references.citation: Immunol Lett. 2003 May 1;86(3):277-80
references.pmid: 12706531
references.citation: Nat Med. 2003 May;9(5):562-7
references.pmid: 12704383
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):5986-90
references.pmid: 12721360
references.citation: J Exp Med. 2003 Dec 15;198(12):1951-7
references.pmid: 14662908
references.citation: Clin Exp Immunol. 2004 Jan;135(1):1-8
references.pmid: 14678257
references.citation: Exp Dermatol. 2003 Dec;12(6):755-60
references.pmid: 14714554
references.citation: Nat Med. 2004 Sep;10(9):942-9
references.pmid: 15322536
references.citation: Immunity. 2004 Oct;21(4):467-76
references.pmid: 15485625
references.citation: J Invest Dermatol. 1993 Nov;101(5):701-5
references.pmid: 7693825
references.citation: Nature. 1997 Jun 26;387(6636):861
references.pmid: 9202117
references.citation: J Invest Dermatol. 1998 Oct;111(4):645-9
references.pmid: 9764847
references.citation: J Invest Dermatol. 1998 Dec;111(6):1072-8
references.pmid: 9856819
references.citation: J Exp Med. 2005 Jan 17;201(2):233-40
references.pmid: 15657292
references.citation: Nat Immunol. 2005 Nov;6(11):1133-41
references.pmid: 16200068
references.citation: Nat Immunol. 2005 Nov;6(11):1123-32
references.pmid: 16200070
references.citation: Nat Immunol. 2005 Nov;6(11):1069-70
references.pmid: 16239919
references.citation: Mediators Inflamm. 2005 Oct 24;2005(5):273-9
references.pmid: 16258194
references.citation: J Biol Chem. 2006 Jan 27;281(4):2005-11
references.pmid: 16319062
references.citation: Immunity. 2006 Feb;24(2):179-89
references.pmid: 16473830
references.citation: Nat Rev Immunol. 2006 Apr;6(4):329-33
references.pmid: 16557264
references.citation: J Exp Med. 2006 Apr 17;203(4):871-81
references.pmid: 16606666
references.citation: J Invest Dermatol. 2006 May;126(5):1059-70
references.pmid: 16484986
references.citation: Am J Hum Genet. 2006 May;78(5):827-51
references.pmid: 16642438
references.citation: Nature. 2006 May 11;441(7090):231-4
references.pmid: 16648837
references.citation: Nature. 2006 May 11;441(7090):235-8
references.pmid: 16648838
references.citation: Nature. 2006 May 11;441(7090):166-8
references.pmid: 16688162
references.citation: Immunity. 2006 Jun;24(6):677-88
references.pmid: 16782025
references.citation: J Immunol. 2006 Jul 1;177(1):566-73
references.pmid: 16785554
references.citation: J Exp Med. 2006 Jul 10;203(7):1685-91
references.pmid: 16818675
references.citation: J Clin Invest. 2006 Aug;116(8):2094-104
references.pmid: 16886058
references.citation: J Clin Invest. 2006 Aug;116(8):2105-14
references.pmid: 16886059
references.citation: Am J Hum Genet. 2007 Feb;80(2):273-90
references.pmid: 17236132
references.citation: N Engl J Med. 2007 Feb 8;356(6):580-92
references.pmid: 17287478
references.citation: Nature. 2007 Feb 22;445(7130):866-73
references.pmid: 17314973
references.citation: J Invest Dermatol. 2008 Jul;128(7):1653-61
references.pmid: 18219280
references.citation: Nat Immunol. 2007 Apr;8(4):345-50
references.pmid: 17375096
references.citation: J Immunol. 2007 Jun 1;178(11):6730-3
references.pmid: 17513719
references.citation: Nat Med. 2007 Jul;13(7):836-42
references.pmid: 17603494
references.citation: J Immunol. 2007 Aug 1;179(3):1423-6
references.pmid: 17641006
references.citation: Nat Immunol. 2007 Sep;8(9):950-7
references.pmid: 17676044
references.citation: Nat Immunol. 2007 Sep;8(9):942-9
references.pmid: 17676045
references.citation: Nature. 2007 Oct 4;449(7162):564-9
references.pmid: 17873860
references.citation: Clin Dermatol. 2007 Nov-Dec;25(6):616-24
references.pmid: 18021900
references.citation: J Exp Med. 2007 Dec 24;204(13):3183-94
references.pmid: 18039949
references.citation: Nat Genet. 2008 Jan;40(1):23-5
references.pmid: 18059266
references.citation: J Immunol. 2008 Feb 1;180(3):1913-20
references.pmid: 18209089
references.citation: J Invest Dermatol. 2000 Jul;115(1):81-7
references.pmid: 10886512